Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J&J's Gorsky On Janssen's COVID-19 Vaccine Timeline, Scale-Up and Back Story

Dec 07 2020

• By Jessica Merrill

Alex Gorsky — J&J CEO Alex Gorsky

Related Content

Coronavirus Notebook: Moderna Claims 94.5% Vaccine Efficacy, Janssen Starts Second ENSEMBLE Trial

Nov 16 2020

UK Grants First Worldwide Authorization For Pfizer/BioNTech COVID-19 Vaccine

Dec 02 2020

AZ Will Sideline ‘Lucky Mistake’ To Secure COVID-19 Vaccine Approval

Nov 27 2020

Coronavirus Update: J&J Pauses COVID-19 Vaccine Trial After Unexplained Illness

Oct 13 2020

Related Companies

Johnson & Johnson

Pfizer Inc.

Moderna, Inc.

BioNTech SE

Additional Topics

Coronavirus COVID-19 Vaccines Leadership Business Strategies Commercial BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window